VSG switching in Trypanosoma brucei: antigenic variation analysed using RNAi in the absence of immune selection
Article first published online: 17 AUG 2005
Volume 57, Issue 6, pages 1608–1622, September 2005
How to Cite
Aitcheson, N., Talbot, S., Shapiro, J., Hughes, K., Adkin, C., Butt, T., Sheader, K. and Rudenko, G. (2005), VSG switching in Trypanosoma brucei: antigenic variation analysed using RNAi in the absence of immune selection. Molecular Microbiology, 57: 1608–1622. doi: 10.1111/j.1365-2958.2005.04795.x
- Issue published online: 17 AUG 2005
- Article first published online: 17 AUG 2005
- Accepted 27 June, 2005.
Trypanosoma brucei relies on antigenic variation of its variant surface glycoprotein (VSG) coat for survival. We show that VSG switching can be efficiently studied in vitro using VSG RNAi in place of an immune system to select for switch variants. Contrary to models predicting an instant switch after inhibition of VSG synthesis, switching was not induced by VSG RNAi and occurred at a rate of 10−4 per division. We find a highly reproducible hierarchy of VSG activation, which appears to be capable of resetting, whereby more than half of the switch events over 12 experiments were to one of two VSGs. We characterized switched clones according to switch mechanism using marker genes in the active VSG expression site (ES). Transcriptional switches between ESs were the preferred switching mechanism, whereby at least 10 of the 17 ESs identified in T. brucei 427 can be functionally active in vitro. We could specifically select for switches mediated by DNA rearrangements by inducing VSG RNAi in the presence of drug selection for the active ES. Most of the preferentially activated VSGs could be activated by multiple mechanisms. This VSG RNAi-based procedure provides a rapid and powerful means for analysing VSG switching in African trypanosomes entirely in vitro.